The Current Ratio as of December 2024 (TTM) for Renalytix Plc (RNLX) is 0.53

According to Renalytix Plc’s latest financial reports and current stock price. The company's current Current Ratio is 0.53. This represents a change of -19.16% compared to the average of 0.66 of the last 4 quarters.

Renalytix Plc (RNLX) Historical Current Ratio (quarterly & annually)

How has RNLX Current Ratio performed in the past?

The mean historical Current Ratio of Renalytix Plc over the last ten years is 5.08. The current 0.53 Current Ratio has changed 948.56% with respect to the historical average. Over the past ten years (40 quarters), RNLX's Current Ratio was at its highest in in the September 2020 quarter at 22.75. The Current Ratio was at its lowest in in the December 2001 quarter at 0.

Renalytix Plc (RNLX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Renalytix Plc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Renalytix Plc (RNLX) Average Current Ratio

How has RNLX Current Ratio performed in the past?

The current Current Ratio of Renalytix Plc (RNLX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Renalytix Plc (RNLX) Current Ratio vs. Peers

How is RNLX’s Current Ratio compared to its peers?

Renalytix Plc’s Current Ratio is greater than Streamline Health Solutions, Inc. (0.46), less than HealthStream, Inc. (1.32), greater than National Research Corporation (0.47), less than Computer Programs and Systems, Inc. (1.80), less than NextGen Healthcare, Inc. (2.52), less than Forian Inc. (1.85), less than Tabula Rasa HealthCare, Inc. (1.67), less than Aclarion, Inc. (2.80), greater than Mangoceuticals, Inc. (0.07), less than Science 37 Holdings, Inc. (4.17), less than Akili, Inc. (5.80), less than Augmedix, Inc. (1.66), less than HealthEquity, Inc. (3.20), less than Health Catalyst, Inc. (1.41), less than Progyny, Inc. (2.62), less than R1 RCM Inc. (1.79),

Build a custom stock screener for Renalytix Plc (RNLX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Renalytix Plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Renalytix Plc (RNLX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Renalytix Plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.